news Trevi Therapeutics Announces Company Updates Ahead of 14th Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference01/08/2025Trevi Therapeutics Announces Pricing of $50 Million Underwritten Offering12/16/2024Trevi Therapeutics Announces Positive Outcome from Sample Size Re-estimation Resulting in No Change to the Current Sample Size for the Phase 2b CORAL Trial in Idiopathic Pulmonary Fibrosis Patients with Chronic Cough12/12/2024 VIEW ALL NEWS contact Trevi Therapeutics 195 Church Street, 16th Floor New Haven, CT 06510 map (203) 304-2499 email us
